Accelerate Diagnostics Inc EBITDA margin
Cos'è EBITDA margin di Accelerate Diagnostics Inc?
EBITDA margin di Accelerate Diagnostics Inc è -609.36%
Qual è la definizione di EBITDA margin?
EBITDA margin is a profitability ratio that measures how much EBITDA the company generates as a percentage of revenue.
ttm (trailing twelve months)
EBITDA margin measures how much of EBITDA is generated as a percentage of sales. It measures the company’s operating profit as a percentage of its revenue and is calculated as EBITDA (earnings before interest, taxes, depreciation, and amortization) divided by total revenue.
EBITDA margin also helps with judging the effectiveness of cost-cutting processes at the company. The higher the company’s EBITDA margin, the lower operating expenses are in respect to revenue. As a result, a higher EBITDA margin is considered more favorable. Smaller companies can have higher EBITDA margins since they are able to operate more efficiently and maximize their profitability.
EBITDA excludes interest on debt, taxes, and capital expenditures, the margin does not provide a perfectly clear estimate of the business’s cash flow generation. Furthermore, EBITDA margin is not recognized as a GAAP (generally accepted accounting principles) metric.
EBITDA margin di aziende nel Health Care settore su NASDAQ rispetto a Accelerate Diagnostics Inc
Cosa fa Accelerate Diagnostics Inc?
accelerate diagnostics, inc. (nasdaq:axdx), is an in vitro diagnostics company focused on developing and commercializing innovative systems for the rapid identification and antimicrobial susceptibility testing of infectious pathogens. the company's revolutionary id/ast platform utilizes a proprietary process with both genomic and phenotypic detection technologies that significantly decreases time to result while achieving high sensitivity and specificity. in addition to the id/ast development pipeline, the company also owns and licenses its proprietary optichem™ surface coatings technology, which has numerous applications for binding in bio-analytical systems, such as microarrays.
Aziende con ebitda margin simili a Accelerate Diagnostics Inc
- KULR Technology ha EBITDA margin di -615.27%
- Sorrento Therapeutics ha EBITDA margin di -614.74%
- Cohen & Steers MLP Income and Opportunity Fund Inc ha EBITDA margin di -614.53%
- Cue Biopharma Inc ha EBITDA margin di -612.37%
- Neuropathix ha EBITDA margin di -612.32%
- Suven Life Sciences ha EBITDA margin di -609.59%
- Accelerate Diagnostics Inc ha EBITDA margin di -609.36%
- ProStar ha EBITDA margin di -608.76%
- ClearVue Technologies ha EBITDA margin di -608.61%
- e Actiplay SA ha EBITDA margin di -606.92%
- iBio Inc ha EBITDA margin di -606.29%
- GlycoMimetics Inc ha EBITDA margin di -604.90%
- Æterna Zentaris ha EBITDA margin di -603.74%